参考文献

［1］ 陈香美. 肾脏病学高级教程 [M]. 北京: 中华医学电子音像出版社, 2017.

［2］ ZHANG L, LONG J, JIANG W, et al. Trends in chronic kidney disease in China [J]. N Engl J Med, 2016, 375 (9): 905-906.

［3］ YANG Y, ZHANG Z, ZHUO L, et al. The spectrum of biopsy-proven glomerular disease in China: A Systematic Review [J]. Chin Med J (Engl), 2018, 131 (6): 731-735.

［4］ ANDRESDOTTIR G, JENSEN M L, CARSTENSEN B, et al. Improved prognosis of diabetic nephropathy in type 1 diabetes [J]. Kidney Int, 2015, 87 (2): 417-426.

［5］ THOMAS M C, BROWNLEE M, SUSZTAK K, et al. Diabetic kidney disease [J]. Nat Rev Dis Primers, 2015, 1: 15018.

［6］ HU J, YANG S, WANG Y, et al. Serum bisphenol A and progression of type 2 diabetic nephropathy: a 6-year prospective study [J]. Acta Diabetol, 2015, 52 (6): 1135-1141.

［7］ WANG L, GAO P, ZHANG M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013 [J]. JAMA, 2017, 317 (24): 2515-2523.

［8］ MA R C, COOPER M E. Genetics of Diabetic Kidney Disease-From the Worst of Nightmares to the Light of Dawn [J]？J Am Soc Nephrol, 2017, 28 (2): 389-393.

［9］ ZACCARDI F, DHALWANI N N, WEBB D R, et al. Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates [J]. Diabetologia, 2018, 61 (7): 1592-1602.

［10］ SARAN R, ROBINSON B, ABBOTT K C, et al. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States [J]. Am J Kidney Dis, 2017, 69 (3 Suppl 1): A7-A8.

［11］ FIORENTINO M, BOLIGNANO D, TESAR V, et al. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies [J]. Nephrol Dial Transplant, 2017, 32 (1): 97-110.

［12］ BELLO A K, LEVIN A, TONELLI M, et al. Assessment of global kidney health care status [J]. JAMA, 2017, 317 (18):1864-1881.

［13］ PENG H, LI Y, WANG C, et al. ROCK1 Induces endothelial-to-mesenchymal transition in glomeruli to aggravate albuminuria in diabetic nephropathy [J]. Sci Rep, 2016, 6: 20304.

［14］ WEN C P, CHANG C H, TSAI M K, et al. Diabetes, with early kidney involvement may shorten life expectancy by 16 years [J]. Kidney Int, 2017, 92 (2): 388-396.

［15］ NAVANEETHAN S D, SCHOLD J D, JOLLY S E, et al. Diabetes, control and the risks of esrd and mortality in patients with CKD [J]. Am J Kidney Dis, 2017, 70 (2): 191-198.

［16］ DUNKLER D, KOHL M, HEINZE G, et al. Modifiable lifestyle and social factors affect chronic kidney disease in high-risk inpiduals with type 2 diabetes mellitus [J]. Kidney Int, 2015, 87 (4): 784-791.

［17］ TOPPE C, MOLLSTEN A, SCHON S, et al. Socio-economic factors infLUencing the development of end-stage renal disease in people with Type 1 diabetes-a LONGitudinal population study [J]. Diabet Med, 2017, 34 (5): 676-682.